Fibrobiologics

FBLG · NASDAQ

$0.9199−$0.0199 (−2.12%)TodayMarket closed ·
Prev close $0.9398

Who owns FBLG

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 26.8% of FBLG’s shares.

  • Armistice Capital LLC9.5%
  • Golden Knight Inc LP5.6%
  • O'Heeron (Peter)4.9%
  • The Lind Partners, LLC2.6%
  • Next 6 largest institutions4.3%
  • All other shareholders73.2%
Top institutional holders of FBLG
HolderShares% of shares
Armistice Capital LLC577.63K9.50%
Golden Knight Inc LP337.49K5.55%
O'Heeron (Peter)297.91K4.90%
The Lind Partners, LLC157.96K2.60%
Cascade Financial Partners, LLC108.83K1.79%
Fund Evaluation Group, LLC51.79K0.85%
Geode Capital Management, L.L.C.30.30K0.50%
Vanguard Capital Management, LLC27.77K0.46%
Qube Research & Technologies Ltd24.31K0.40%
BlackRock Institutional Trust Company, N.A.18.24K0.30%

Largest mutual fund holders

Top mutual fund holders of FBLG
HolderShares% of shares
Vanguard Extended Market Index Fund27.77K0.46%
Fidelity Extended Market Index Fund24.38K0.40%
Abante Quant Value, FI13.68K0.22%
Fidelity Series Total Market Index Fund2.57K0.04%
Fidelity Total Market Index Fund2.27K0.04%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of FBLG in the last 6 months.

Latest FBLG insider transactions
InsiderTypeSharesValue
Khoja HamidAward298.51K—
Khoja HamidAward298.51K$500.00K
Cilento Richard C. Jr.Award30.80K—
Niklas Victoria Ninon OliviaAward30.80K—
Link MatthewAward30.80K—
Hoffman Robert E.Award30.80K—
Khoja HamidAward61.61K—
GARCIA RUBEN AAward61.61K—
O'HEERON PETEAward92.41K—
Davis JasonAward61.61K—

Short interest

Settled Sep 30, 2026

Shares short
522.11K
Days to cover
3.82
% of shares outstanding
8.59%
Average daily volume
136.52K
Change since last report
−21.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.